文献
J-GLOBAL ID:201802238996022060
整理番号:18A1012418
EGFR T790M変異陽性進行非小細胞肺癌の日本人患者におけるオシメルチニブ:AURA3試験
Osimertinib in Japanese patients with EGFR T790M mutation-positive advanced non-small-cell lung cancer: AURA3 trial
著者 (10件):
Akamatsu Hiroaki
(Third Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan)
,
Katakami Nobuyuki
(Institute of Biomedical Research and Innovation, Kobe, Japan)
,
Okamoto Isamu
(Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan)
,
Kato Terufumi
(Kanagawa Cardiovascular and Respiratory Center, Yokohama, Japan)
,
Kim Young Hak
(Graduate School of Medicine, Kyoto University, Kyoto, Japan)
,
Imamura Fumio
(Osaka International Cancer Institute, Osaka, Japan)
,
Shinkai Masaharu
(Yokohama City University Medical Center, Yokohama, Japan)
,
Hodge Rachel A.
(AstraZeneca, Royston, Hertfordshire, UK)
,
Uchida Hirohiko
(AstraZeneca, Osaka, Japan)
,
Hida Toyoaki
(Aichi Cancer Center Hospital, Nagoya, Japan)
資料名:
Cancer Science (Web)
(Cancer Science (Web))
巻:
109
号:
6
ページ:
1930-1938
発行年:
2018年
JST資料番号:
U0505A
ISSN:
1349-7006
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
アメリカ合衆国 (USA)
言語:
英語 (EN)